Ablation Combined With PD-1 in HCC: Phase II Study
NCT04652440
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
UNKNOWN
Status
30
Enrollment
OTHER
Sponsor class
Conditions
Hepatocellular Carcinoma
Interventions
DRUG:
PD-1 monoclonal antibody
PROCEDURE:
Radiofequencey or microwave ablation
Sponsor
Sun Yat-sen University